Vanguard Personalized Indexing Management
AMRX icon

Vanguard Personalized Indexing Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Buy
13,057
+1,779
+16% +$24.4K ﹤0.01% 1853
2026
Q1 		$140K Buy
+11,278
New +$151K ﹤0.01% 1894

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Personalized Indexing Management's AMRX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Amneal Pharmaceuticals (AMRX) stake by 16% in Q2 2026, buying an estimated $24.4K and bringing the position to 13,057 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #1853.

Vanguard Personalized Indexing Management first reported a position in AMRX in Q1 2026 and has held it in 2 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Vanguard Personalized Indexing Management held 13,057 shares of Amneal Pharmaceuticals worth $226K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 1,779 Amneal Pharmaceuticals shares in Q2 2026, an estimated $24.4K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1853 holding.
  • Vanguard Personalized Indexing Management first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.